Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724978 | SCV000332873 | uncertain significance | not provided | 2015-07-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724978 | SCV000727475 | likely benign | not provided | 2019-05-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001468477 | SCV001672531 | likely benign | Duchenne muscular dystrophy | 2023-12-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374454 | SCV002683400 | likely benign | Cardiovascular phenotype | 2020-09-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000724978 | SCV004164717 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | DMD: BP4, BP7 |
Natera, |
RCV001828183 | SCV002080233 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-02-26 | no assertion criteria provided | clinical testing |